• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对正常和突变 CFTR 基因的 CFTR 基因进行单体型分析。

Haplotype analysis of the CFTR gene on normal and mutant CFTR genes.

机构信息

Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran; Krefting Research Centre, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Department of Biology, Faculty of Science, Razi University, Kermanshah, Iran.

出版信息

Mutat Res. 2020 May-Dec;821:111708. doi: 10.1016/j.mrfmmm.2020.111708. Epub 2020 May 23.

DOI:10.1016/j.mrfmmm.2020.111708
PMID:32563932
Abstract

BACKGROUND

Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are responsible for Cystic Fibrosis (CF) disease. Since the distribution of polymorphisms varies among populations, a comparison between the frequency of CFTR polymorphisms in patients and healthy population may further identify their role in CF disease. The results obtained from this research may facilitate the prediction of disease phenotype in prenatal diagnosis or newborn screening program as well as determine the possible associations between haplotypes and specific mutations.

METHODS

Blood samples collected from 27 unrelated West Iranian families contain at least one CF patient and 55 control families with no history of CF. Samples were analyzed for c.1210-12 T [5-9], c.1242-35-1242-12GT [8-10], c.744-33GATT [6-8] and c.869 + 11C > T polymorphisms by automated direct DNA sequencing following DNA extraction.

RESULTS

Our results showed that the T7 allele is the most common allele in normal and non-ΔF508 CF chromosomes with the frequencies of 93.6% and 100%, respectively. Conversely, T9 was the only allele detected in ΔF508 chromosomes. Moreover, the c.1242-35-1242-12GT analysis showed that (TG)11 repeat was the most common dinucleotide repeat in both, non-ΔF508 and normal chromosomes with the frequencies of 91% and 71%, respectively. The c.744-33GATT and c.869 + 11C > T polymorphism analyses indicated that (GATT)6 and T allele are only found in ΔF508 CF chromosomes. Besides, the [T7-TG11-GATT7-C] haplotype was the most common haplotype in both, normal and non-ΔF508 CF subjects while the [T9-TG10- GATT6-T] haplotype was only detected in CF patients carrying ΔF508 mutation.

CONCLUSIONS

Our findings identified an informative haplotype that could be used in genetic counseling, prenatal diagnosis and future screening of CF in Iran.

摘要

背景

囊性纤维化跨膜电导调节因子(CFTR)基因突变是囊性纤维化(CF)疾病的病因。由于多态性在不同人群中的分布存在差异,因此比较 CFTR 多态性在患者和健康人群中的频率可能有助于进一步确定其在 CF 疾病中的作用。这项研究的结果可以帮助预测产前诊断或新生儿筛查计划中的疾病表型,并确定特定突变与单倍型之间的可能关联。

方法

从 27 个不相关的伊朗西部家庭中采集血液样本,每个家庭至少有一名 CF 患者和 55 个无 CF 病史的对照家庭。在提取 DNA 后,通过自动直接 DNA 测序分析 c.1210-12T[5-9]、c.1242-35-1242-12GT[8-10]、c.744-33GATT[6-8]和 c.869+11C>T 多态性。

结果

我们的结果表明,T7 等位基因是正常和非 ΔF508 CF 染色体中最常见的等位基因,频率分别为 93.6%和 100%。相反,T9 是 ΔF508 染色体中唯一检测到的等位基因。此外,c.1242-35-1242-12GT 分析表明,(TG)11 重复是在非 ΔF508 和正常染色体中最常见的二核苷酸重复,频率分别为 91%和 71%。c.744-33GATT 和 c.869+11C>T 多态性分析表明,(GATT)6 和 T 等位基因仅在 ΔF508 CF 染色体中发现。此外,[T7-TG11-GATT7-C]单倍型是正常和非 ΔF508 CF 受试者中最常见的单倍型,而[T9-TG10-GATT6-T]单倍型仅在携带 ΔF508 突变的 CF 患者中检测到。

结论

我们的研究结果确定了一个信息丰富的单倍型,可用于伊朗的遗传咨询、产前诊断和未来的 CF 筛查。

相似文献

1
Haplotype analysis of the CFTR gene on normal and mutant CFTR genes.对正常和突变 CFTR 基因的 CFTR 基因进行单体型分析。
Mutat Res. 2020 May-Dec;821:111708. doi: 10.1016/j.mrfmmm.2020.111708. Epub 2020 May 23.
2
CFTR haplotypes in northern Iranian population.伊朗北部人群中的 CFTR 单倍型。
Gene. 2013 Jan 1;512(1):55-60. doi: 10.1016/j.gene.2012.09.096. Epub 2012 Oct 5.
3
Cystic fibrosis transmembrane regulator haplotypes in households of patients with cystic fibrosis.囊性纤维化患者家庭中的囊性纤维化跨膜传导调节因子单倍型
Gene. 2018 Jan 30;641:137-143. doi: 10.1016/j.gene.2017.10.052. Epub 2017 Oct 18.
4
Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.伊朗囊性纤维化患者CFTR基因分析:鉴定出八个新突变
J Cyst Fibros. 2008 Mar;7(2):102-9. doi: 10.1016/j.jcf.2007.06.001. Epub 2007 Jul 27.
5
A haplotype framework for cystic fibrosis mutations in Iran.伊朗囊性纤维化突变的单倍型框架。
J Mol Diagn. 2006 Feb;8(1):119-27. doi: 10.2353/jmoldx.2006.050063.
6
CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中的CF基因与囊性纤维化跨膜传导调节因子表达
J Am Soc Nephrol. 2000 Dec;11(12):2285-2296. doi: 10.1681/ASN.V11122285.
7
Mutation and new polymorphisms insight in introns 11 to 14a of CFTR gene of northern Iranian cystic fibrosis patients.伊朗北部囊性纤维化患者CFTR基因第11至14a内含子的突变及新多态性研究
Gene. 2015 Jun 15;564(2):193-6. doi: 10.1016/j.gene.2015.03.056. Epub 2015 Mar 28.
8
Intra- and extragenic marker haplotypes of CFTR mutations in cystic fibrosis families.囊性纤维化家族中CFTR突变的基因内和基因外标记单倍型。
Hum Genet. 1992 Feb;88(4):417-25. doi: 10.1007/BF00215676.
9
Spectrum of CFTR mutations in Chechen cystic fibrosis patients: high frequency of c.1545_1546delTA (p.Tyr515X; 1677delTA) and c.274G>A (p.Glu92Lys, E92K) mutations in North Caucasus.高加索地区 Chechen 囊性纤维化患者 CFTR 基因突变谱:c.1545_1546delTA(p.Tyr515X;1677delTA)和 c.274G>A(p.Glu92Lys,E92K)突变高频。
BMC Med Genet. 2019 Mar 21;20(1):44. doi: 10.1186/s12881-019-0785-z.
10
[Analysis of the spectra of mutations and polymorphic loci of cystic fibrosis transmembrane conductance regulator in the population of Bashkortostan].[巴什基尔斯坦人群中囊性纤维化跨膜传导调节因子的突变和多态性位点谱分析]
Genetika. 2002 Sep;38(9):1270-5.

引用本文的文献

1
Increased prevalence of variants and susceptibility to CRS: A real-world study based on Chinese children.变应性鼻炎(CRS)变异的患病率增加及其易感性:一项基于中国儿童的真实世界研究
Heliyon. 2024 Mar 14;10(7):e27681. doi: 10.1016/j.heliyon.2024.e27681. eCollection 2024 Apr 15.
2
Novel therapeutic approaches for the management of cystic fibrosis.囊性纤维化治疗的新型方法
Multidiscip Respir Med. 2020 Nov 26;15(1):690. doi: 10.4081/mrm.2020.690. eCollection 2020 Jan 28.